In vitro calcium antagonist activity of lercanidipine and its enantiomers

Journal of Cardiovascular Pharmacology

Volumn 29, Issue SUPPL. 1, 1997, Pages

  Leonardi, A ^a   Poggesi, E ^a   Taddei, C ^a   Guarneri, L ^a   Angelico, P ^a   Accomazzo, M R ^b   Nicosia, S ^b   Testa, R ^a  

^a Recordati SpA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

1,4 Dihydropyridine calcium antagonists; In vitro studies; Lercanidipine; Lercanidipine enantiomers

Indexed keywords

AMLODIPINE; ANGIOTENSIN; CALCIUM ANTAGONIST; CALCIUM CHANNEL; CATECHOLAMINE; DIHYDROPYRIDINE; LERCANIDIPINE; NICARDIPINE; NIFEDIPINE; NIGULDIPINE; NITRENDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHEMICAL STRUCTURE; ENANTIOMER; GUINEA PIG; HEART DEPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030969496     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199729001-00003     Document Type: Article

References (24)

1. Godfraind T. Classification of calcium antagonists. Am J Cardiol 1987;59:11B-23B.
2. Saini RK. Calcium antagonists. In: Antonaccio MJ, ed. Cardiovascular pharmacology. New York: Raven Press, 1984:415-52.
3. Kaplan NM. Calcium and blood pressure. Cardiovasc Drugs Ther 1988;2:269-74.
4. Sorkin EM, Clissod SP, Brogden RN. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985;30:182-274.
5. Soward AL, Vanhaleweyk GLJ, Serruys PW. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review. Drugs 1986;32:66-101.
6. Nardi D, Leonardi A, Graziani G, Bianchi G. Asymmetrical diesters of 1,4-dihydropyridine-3,5-dicarboxylic acid. European patent application 0153016B1, 1985.
7. Guarneri L, Angelico P, Ibba M, et al. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Arzneimittelforschung 1996;46:15-24.
8. Oliva D, Accomazzo M R, Giovanazzi S, Nicosia S. Correlation between leukotriene LTD4-induced contraction and cytosolic calcium elevation: a quantitative and simultaneous evaluation in smooth muscle. J Pharmacol Exp Ther 1994;268:159-66.
9. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
10. 50) of an enzyme reaction. Biochem Pharmacol 1973;22:3099-108.
11. Nyborg NCB, Mulvany MJ. Effect of felodipine, a new dihydropyridine vasodilator, on contractile responses to potassium, noradrenaline, and calcium in mesenteric resistance vessels of the rat. J Cardiovasc Pharmacol 1984;6:499-505.
12. 45Ca uptake in rat aorta. Eur J Pharmacol 1988;158:183-90.
13. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979;59:606-718.
14. Towart R, Wehinger E, Meyer H, Kazda S. The effect of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittelforschung 1982;32:338-46.
15. Hof R, Hof A, Ruegg T, Cook S, Vogel A. Stereoselectivity at the calcium channel: different profiles of haemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol 1986;8:221-6.
16. Muto K, Kuroda T, Kavato H, Karasawa A, Kubo K, Nakamizo N. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-methyl-4-(3-nitrophenyl-3,5-pyridine) dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinil ester. Arzneimittelforschung 1988;38:1662-5.
17. Brisac A, Champeroux P, Lucet B, Laurent S, Schmitt H. Central and peripheral hypotensive effects of the optical isomers of nicardipine, a dihydropyridine calcium channel antagonist in rats. Eur J Pharmacol 1988;146:171-4.
18. David M, Hofman P, Wegmann E, Zech K. Stereoselectivity in the disposition and metabolism of (+) and (-) niguldipine in dogs [Abstract]. Proc 11th European Workshop on Drug Metabolism. 1988: no. 1.28.
19. Goldmann S, Soltefuss J. 1,4-Dihydropyridines: effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew Chem Int [Ed Engl] 1991;30:1559-78.
20. Herbette LG, Vant Erve YMH, Rhodes DG. Interaction of 1,4-dihydropyridine calcium antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptor. J Mol Cell Cardiol 1989;21:187-201.
21. 1-adrenoceptors. Eur J Pharmacol Mol Pharmacol 1989;172: 131-45.
22. Sironi G, Montagna E, Greto L, Bianchi G, Leonardi A, Testa R. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Arzneimittelforschung 1996;46: 145-52.
23. Richard MO. Pharmacocinétique des antagonistes calciques. Therapie 1993;48:651-7.
24. Zanchetti A. Role of calcium antagonists in systemic hypertension. Am J Cardiol 1987;59:130B-6B.